Samsung Biologics quarterly sales hit W1tr for first time
简介Samsung Biologics said Wednesday it exceeded 1 trillion won ($741 million) in quarterly sales for th ...
Samsung Biologics said Wednesday it exceeded 1 trillion won ($741 million) in quarterly sales for the first time, following the operation of its fourth plant and profits generated by long-term contract manufacturing orders.
According to regulatory filings for the July-September period, Samsung Biologics’ quarterly sales on a consolidated basis hit a record high of 1.34 trillion won, marking 18 percent on-year growth.
Operating profits were 318 billion won during the same period, down 2 percent from a year prior.
Cumulative sales and operating profits were 2.6 trillion won and 763 trillion won as of the third quarter this year, up 29 percent and 14 percent from the same period last year, respectively.
The company said its increased production capacity has been driving up its sales overall. The fourth plant with a production capacity of 240,000 liters went into full operation in June.
New contract manufacturing orders also contributed to upbeat earnings. As of October, its cumulative orders secured amounts to $11.8 billion.
Samsung Bioepis, a biosimilar developer wholly owned by Samsung Biologics, meanwhile, saw a drop in its financial showings. It recorded 262 billion won in sales and 49.2 billion won in operating profits, down 3 percent and 37 percent on-year, respectively.
“To respond quickly to the growing demand for biopharmaceuticals, Samsung Biologics is currently building its fifth plant with the goal of completing it by April 2025,” said an official from Samsung Biologics.
The fifth plant, upon completion, will have an annual production capacity of 180,000 liters.
The American epic sci-fi film "Dune," which grossed $402 million worldwide, will hit local theaters ...
US Defense Secretary Lloyd Austin highlighted America's ability to address "crises in multiple theat ...
Korean science fiction writer Bae Myung-hoon on Wednesday emphasized the importance of bridging the ...
Fragile yet strong, G Gallery's 'Thick Skin' showcases two emerging artists
PM makes official visit to Denmark to promote Expo bid
尹 “하마스 무차별 공격 규탄”...척 슈머 등 美 상원 대표단 접견
Aespa to return with 4th EP ‘Drama’ next month
USAID official urges boosted development cooperation among S. Korea, US, Japan as 'like
Samsung SDI, Stellantis to set up 2nd JV plant in Indiana
- [사진] 용산 팔도장터 찾아 떡메치기
- Unification minister to visit Britain, Germany
- Political strife may delay Korea’s launch of new space agency
- Jakarta lights up in pink with SMTown Live 2023
- Breadwinners in their 60s or above double in 9 years
- [KH Explains] Lotte goes all
- S. Korea to step up quarantine efforts against animal diseases
- N.Korea blasts Yoon for denouncing military ties with Russia at UN
- [Herald Interview] As a wanderer, Yoshitomo Nara does not confine himself to art
- Yoon's approval rating edges up after 6
- S. Korea, US revise deterrence strategy amid growing NK threats
- Top diplomats of S. Korea, US, Japan hold talks on margins of APEC summit
- Seoul shares open higher on Wall Street gains
- Container shipping costs for US west coast rise 7 pct in October
- Ive, aespa, NewJeans, StayC and Kiss of Life join star
- UNC members renew commitment against any NK armed attack
- [Korean History] In 2005, science world’s biggest scandal unravels in Seoul
- [Herald Interview] ‘Daily Dose of Sunshine’ director, actor say drama consoled them
- US approves possible sale of SM
- Animal shelter busted for killing and burying hundreds of pets
- Samsung Bioepis to develop MSD's Keytruda biosimilar
- FNC's new boy group Ampers&One debuts with energetic, youthful single
- Han Sung Motor commits to give back to society
- ‘Concrete Utopia’ clinches best picture at Daejong Film Awards
- Prix Medicis winning Han Kang wants next novel to be like 'spring'
- Stray Kids to perform at 2023 Billboard Music Awards
- Finance minister calls for reenactment of corporate restructuring act
- [Herald Interview] UAE economy minister urges to expand business partnerships
- Seoul subway to hold second strike Nov. 22
- Production teams called out for carelessness